Dr. Trevejo paper in Nature Biotechnology highlights critical considerations in the race to develop COVID-19 vaccines and antibody countermeasures.

In this important race to develop protections and treatments, key facets of the biology of SARS-CoV-2 are critical for consideration. A recent Nature Biotechnology publication written in collaboration with HelixNano and Dr. George Church of the Harvard, Wyss Institute discusses these biological paradigms of SARS-CoV-2. We discuss some of the important considerations and measures to be taken for the creation and development of vaccines as well as monoclonal antibodies.

See the article in here

Trevejo article in Nature Biotechnology

See the editorial here